Is Patent Eligibility Doctrine in Need of Reform?

  Рет қаралды 7,241

The Federalist Society

The Federalist Society

Ай бұрын

Between 2010-2014, the Supreme Court handed down four decisions resulting in the Mayo-Alice two-step test for what counts as an invention or discovery eligible for patent protection. In the ensuing decade, the issue of whether this test is indeterminate, too restrictive, or both, has been vigorously debated by lawyers, judges, and scholars. Recently, Senators Thom Tillis (R-NC) and Christopher Coons (D-DE) introduced the Patent Eligibility Restoration Act (PERA), which would abrogate the Mayo-Alice test among other substantive and procedural reforms to patent eligibility doctrine. This webinar discussed PERA and its implications for the U.S. innovation economy as leader in innovation in the 21st century facing new challenges from global competitors like China.
Featuring:
Joseph Matal, Principal, Clear IP, LLC
Prof. Kristen Osenga, Austin E. Owen Research Scholar & Professor of Law, The University of Richmond School of Law
Hon. Randall R. Rader, Chief Judge (ret.), U.S. Court of Appeals for the Federal Circuit, and Honorary Professor, Tsinghua University
Moderator: Michael K. Friedland, Founding Partner, Friedland Cianfrani LLP
* * * * *
As always, the Federalist Society takes no position on particular legal or public policy issues; all expressions of opinion are those of the speaker.

Пікірлер: 1
@paxdriver
@paxdriver Ай бұрын
29:12 it's not so complicated to have devoted his entire time to mayo, judge Raider: So, a tool or piece of software that hides the formula for dosage behind the black box of the tool WOULD be patentable, but the problem is that would create an artificial reliance on a tool rather than empowering doctors to simply know the formula. He doesn't seem to understand the actual issue at hand. The unnecessary restrictions locking the formula behind the tool being required to grant the patent, that would be a disservice to society but the simple / proper release of information (the discovery of dosage formula in this case) would not permit the inventor to claim royalty on the discovery, and that is the issue imho.
Understanding the patent examination process
59:25
USPTOvideo
Рет қаралды 50 М.
I Can't Believe We Did This...
00:38
Stokes Twins
Рет қаралды 93 МЛН
MEGA BOXES ARE BACK!!!
08:53
Brawl Stars
Рет қаралды 36 МЛН
孩子多的烦恼?#火影忍者 #家庭 #佐助
00:31
火影忍者一家
Рет қаралды 49 МЛН
Дибала против вратаря Легенды
00:33
Mr. Oleynik
Рет қаралды 5 МЛН
HOW to get your IDEA PATENTED
8:32
inventRightTV
Рет қаралды 38 М.
Arthur N. Rupe Debate: Is the Wealth Tax Constitutional?
1:44:55
The Federalist Society
Рет қаралды 58 М.
Overview of the American Legal System
39:18
University of Virginia School of Law
Рет қаралды 260 М.
Is graphene starting to live up to its hype?
28:03
RAZOR Science Show
Рет қаралды 298 М.
Courthouse Steps Decision: SEC v. Jarkesy
39:53
The Federalist Society
Рет қаралды 184
Trump’s Second Term: Last Week Tonight with John Oliver (HBO)
29:15
LastWeekTonight
Рет қаралды 7 МЛН
AI ROBOTS Are Becoming TOO REAL! - Shocking AI & Robotics 2024 Updates
1:08:58
Patenting Crash Course (Must Watch)
29:04
SHIINE® The Inventor's Journey™
Рет қаралды 66 М.
Lecture 11 - Claim Construction 1
47:01
Patent Law at PennLaw
Рет қаралды 39 М.
I Can't Believe We Did This...
00:38
Stokes Twins
Рет қаралды 93 МЛН